Phathom Pharmaceuticals, Inc. (PHAT) Reports Q4 Loss, Tops Revenue Estimates

Phathom Pharmaceuticals, Inc. (PHAT) came out with a quarterly loss of $0.79 per share versus the Zacks Consensus Estimate of a loss of$ 0.98. This compares to loss of $0.80 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 19.39%. A quarter ago, it was expected that this company would post a loss of$ 1.57 per share when it actually produced a loss of $1.32, delivering a surprise of 15.92%.Over the last four quarters, the compan ...